Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05876754
Title	An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma (ProvIDHe)
Acronym	ProvIDHe
Recruitment	Recruiting
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Servier
Indications	cholangiocarcinoma
Therapies	Ivosidenib
Age Groups:	adult \| senior
Covered Countries	NLD \| ITA \| GBR \| FRA \| ESP \| DEU \| BEL \| AUT \| AUS